Shanghai Biomedical M&A Private Equity Fund Established with a Capital Contribution of 4.66 Billion Yuan

According to the Qichacha APP, recently, the Shanghai Biomedical M&A Private Equity Fund Partnership was established with a capital contribution of 4.66 billion yuan. The business scope includes activities such as equity investment, investment management, and asset management through private equity funds. Qichacha's equity penetration shows that this partnership is jointly held by Chengdu Jiaozi Zhongying Innovation Development Fund Partnership, Tofflon, JUNSHI BIO, and others